☰

Luke H. Hoeppner, Ph.D. - Publications

Affiliations: 
2010 Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ferrari MG, Ganaie AA, Shabenah A, Mansini AP, Wang L, Murugan P, Davicioni E, Wang J, Deng Y, Hoeppner LH, Warlick CA, Konety BR, Saleem M. Identifying and treating ROBO1 /DOCK1 prostate cancer: An aggressive cancer subtype prevalent in African American patients. The Prostate. PMID 32687658 DOI: 10.1002/Pros.24018  0.304
2020 Alam SK, Wang L, Ren Y, Hernandez CE, Kosari F, Roden AC, Yang R, Hoeppner LH. ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation. British Journal of Cancer. PMID 32499571 DOI: 10.1038/S41416-020-0923-6  0.318
2020 Alam SK, Wang L, Ren Y, Hernandez CE, Kosari F, Roden AC, Yang R, Hoeppner LH. Abstract 5956: New molecular mechanisms of small cell lung cancer growth Cancer Research. 80: 5956-5956. DOI: 10.1158/1538-7445.Am2020-5956  0.36
2019 Wang Y, Hoeppner LH, Angom RS, Wang E, Dutta S, Doeppler HR, Wang F, Shen T, Scarisbrick IA, Guha S, Storz P, Bhattacharya R, Mukhopadhyay D. Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β. The Journal of Biological Chemistry. PMID 31492751 DOI: 10.1074/Jbc.Ra119.010152  0.444
2019 Alam SK, Astone M, Liu P, Wang L, Coyle AM, Dankert EN, Hoffman DK, Hall SR, Zhang W, Kuang R, Roden AC, Mansfield AS, Hoeppner LH. Abstract 873: Molecular mechanisms of non-small cell lung cancer growth and drug resistance Cancer Research. 79: 873-873. DOI: 10.1158/1538-7445.Am2019-873  0.345
2018 Ganaie A, Beigh FH, Astone M, Ferrari MG, Maqbool R, Umbreen S, Parray AS, Siddique HR, Hussain T, Murugan P, Morrissey C, Koochekpour S, Deng Y, Konety BR, Hoeppner LH, et al. BMI1 drives metastasis of prostate cancer in Caucasian and African-American men and is a potential therapeutic target: hypothesis tested in race-specific models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30087142 DOI: 10.1158/1078-0432.Ccr-18-1394  0.314
2018 Alam SK, Astone M, Liu P, Hall SR, Coyle AM, Dankert EN, Hoffman DK, Zhang W, Kuang R, Roden AC, Mansfield AS, Hoeppner LH. Abstract 5161: DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration and Akt/Erk-mediated cell survival Cancer Research. 78: 5161-5161. DOI: 10.1158/1538-7445.Am2018-5161  0.394
2015 Hoeppner LH, Sinha S, Wang Y, Bhattacharya R, Dutta S, Gong X, Bedell VM, Suresh S, Chun CZ, Ramchandran R, Ekker SC, Mukhopadhyay D. RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells. Journal of Cell Science. PMID 26136364 DOI: 10.1242/Dev.131599  0.327
2015 Hoeppner LH, Wang Y, Sharma A, Javeed N, Van Keulen VP, Wang E, Yang P, Roden AC, Peikert T, Molina JR, Mukhopadhyay D. Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells. Molecular Oncology. 9: 270-81. PMID 25226814 DOI: 10.1016/J.Molonc.2014.08.008  0.309
2014 Thakur RK, Yadav VK, Kumar A, Singh A, Pal K, Hoeppner L, Saha D, Purohit G, Basundra R, Kar A, Halder R, Kumar P, Baral A, Kumar MJ, Baldi A, et al. Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin. Nucleic Acids Research. 42: 11589-600. PMID 25249619 DOI: 10.1093/Nar/Gku860  0.421
2013 Cao Y, Hoeppner LH, Bach S, E G, Guo Y, Wang E, Wu J, Cowley MJ, Chang DK, Waddell N, Grimmond SM, Biankin AV, Daly RJ, Zhang X, Mukhopadhyay D. Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial α5 integrin. Cancer Research. 73: 4579-90. PMID 23689123 DOI: 10.1158/0008-5472.Can-13-0529  0.379
2012 Hoeppner LH, Phoenix KN, Clark KJ, Bhattacharya R, Gong X, Sciuto TE, Vohra P, Suresh S, Bhattacharya S, Dvorak AM, Ekker SC, Dvorak HF, Claffey KP, Mukhopadhyay D. Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability. Blood. 120: 2167-73. PMID 22674805 DOI: 10.1182/Blood-2012-03-417824  0.315
2011 Hoeppner LH, Secreto FJ, Razidlo DF, Whitney TJ, Westendorf JJ. Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass. The Journal of Biological Chemistry. 286: 10950-9. PMID 21270130 DOI: 10.1074/Jbc.M110.165100  0.666
2009 Hoeppner LH, Secreto F, Jensen ED, Li X, Kahler RA, Westendorf JJ. Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation. Journal of Cellular Physiology. 221: 480-9. PMID 19650108 DOI: 10.1002/Jcp.21879  0.675
2009 Secreto FJ, Hoeppner LH, Westendorf JJ. Wnt signaling during fracture repair. Current Osteoporosis Reports. 7: 64-9. PMID 19631031 DOI: 10.1007/S11914-009-0012-5  0.582
2009 Li X, Hoeppner LH, Jensen ED, Gopalakrishnan R, Westendorf JJ. Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors. Journal of Cellular Biochemistry. 108: 378-87. PMID 19585539 DOI: 10.1002/Jcb.22263  0.671
2009 Hoeppner LH, Secreto FJ, Westendorf JJ. Wnt signaling as a therapeutic target for bone diseases. Expert Opinion On Therapeutic Targets. 13: 485-96. PMID 19335070 DOI: 10.1517/14728220902841961  0.602
2008 Kahler RA, Yingst SM, Hoeppner LH, Jensen ED, Krawczak D, Oxford JT, Westendorf JJ. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation. Matrix Biology : Journal of the International Society For Matrix Biology. 27: 330-8. PMID 18280717 DOI: 10.1016/J.Matbio.2008.01.002  0.673
2007 Westendorf JJ, Hoeppner L. Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment Urologic Oncology: Seminars and Original Investigations. 25: 182. DOI: 10.1016/J.Urolonc.2006.12.008  0.613
2007 Westendorf JJ, Hoeppner L. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells Urologic Oncology: Seminars and Original Investigations. 25: 181-182. DOI: 10.1016/J.Urolonc.2006.12.007  0.582
2007 Westendorf JJ, Hoeppner L. Down-regulation of androgen receptor by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells Urologic Oncology: Seminars and Original Investigations. 25: 180-181. DOI: 10.1016/J.Urolonc.2006.12.006  0.604
2007 Westendorf JJ, Hoeppner L. Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor Urologic Oncology: Seminars and Original Investigations. 25: 180. DOI: 10.1016/J.Urolonc.2006.12.005  0.567
2007 Westendorf JJ, Hoeppner L. Type I collagen receptor ({alpha}2{beta}1) signaling promotes the growth of human prostate cancer cells within the bone Urologic Oncology: Seminars and Original Investigations. 25: 179-180. DOI: 10.1016/J.Urolonc.2006.12.004  0.629
2007 Westendorf JJ, Hoeppner L. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M, Department of Cancer Biology, Vanderbilt University, Nashville, TN Urologic Oncology-Seminars and Original Investigations. 25: 179. DOI: 10.1016/J.Urolonc.2006.12.003  0.405
Show low-probability matches.